The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer - Concepedia

Concepedia

Publication | Open Access

The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer

DOI Full Paper Access

63

Citations

21

References

2006

Year

William A. See, C. Tyrrell

Journal of Cancer Research and Clinical Oncology

UrologyRadiation MedicineRadiation TherapyOverall SurvivalMedicineBrachytherapyBicalutamide 150Advanced Prostate CancerPharmacotherapyProstatic DiseaseOncologyRadiation Oncology

References

	Year	Citations

Page 1